MAA868

MAA868 · Anthos Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAA868, covering 2021-12-07 to 2021-12-07. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-range Finding Study of MAA868 in Patients With Atrial Fibrillation [Phase 2]